Profile | GDS5420 / 214135_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 45.24 | 30 |
GSM1296119 | B_lesional_pre-dose | 77.07 | 36 |
GSM1296076 | C_lesional_pre-dose | 88.93 | 40 |
GSM1296092 | D_lesional_pre-dose | 32.77 | 27 |
GSM1296103 | E_lesional_pre-dose | 52.44 | 32 |
GSM1296078 | F_lesional_pre-dose | 90.04 | 41 |
GSM1296107 | G_lesional_pre-dose | 117.12 | 42 |
GSM1296109 | H_lesional_pre-dose | 116.92 | 42 |
GSM1296080 | I_lesional_pre-dose | 40.27 | 29 |
GSM1296090 | J_lesional_pre-dose | 34.87 | 27 |
GSM1296074 | K_lesional_pre-dose | 59.38 | 36 |
GSM1296111 | L_lesional_pre-dose | 106.92 | 40 |
GSM1296099 | M_lesional_pre-dose | 74.5 | 37 |
GSM1296086 | O_lesional_pre-dose | 45.06 | 30 |
GSM1296117 | P_lesional_pre-dose | 76.47 | 35 |
GSM1296113 | Q_lesional_pre-dose | 148.37 | 45 |
GSM1296096 | R_lesional_pre-dose | 77.44 | 38 |
GSM1296105 | S_lesional_pre-dose | 92.32 | 39 |
GSM1296098 | T_lesional_pre-dose | 89.15 | 38 |
GSM1296101 | U_lesional_pre-dose | 97.92 | 41 |
GSM1296121 | V_lesional_pre-dose | 117.51 | 43 |
GSM1296088 | W_lesional_pre-dose | 32.58 | 26 |
GSM1296082 | X_lesional_pre-dose | 39.63 | 29 |
GSM1296115 | Y_lesional_pre-dose | 100.48 | 40 |
GSM1296084 | Z_lesional_pre-dose | 42.35 | 28 |
GSM1296072 | B_lesional_day8 | 140.86 | 45 |
GSM1296069 | L_lesional_day8 | 130.53 | 43 |
GSM1296071 | P_lesional_day8 | 121.88 | 42 |
GSM1296070 | Y_lesional_day8 | 145.5 | 45 |
GSM1296073 | V_lesional_day8 | 86.15 | 38 |
GSM1296034 | A_lesional_day15 | 175.78 | 49 |
GSM1296041 | G_lesional_day15 | 99.2 | 40 |
GSM1296035 | R_lesional_day15 | 71.61 | 38 |
GSM1296038 | U_lesional_day15 | 61.52 | 34 |
GSM1296047 | B_lesional_day15 | 154.1 | 47 |
GSM1296039 | E_lesional_day15 | 57.28 | 33 |
GSM1296042 | H_lesional_day15 | 118.09 | 42 |
GSM1296043 | L_lesional_day15 | 114.92 | 41 |
GSM1296037 | M_lesional_day15 | 124.68 | 44 |
GSM1296046 | P_lesional_day15 | 165.02 | 47 |
GSM1296044 | Q_lesional_day15 | 209.01 | 51 |
GSM1296045 | Y_lesional_day15 | 141.05 | 44 |
GSM1296025 | C_lesional_day15 | 66.69 | 35 |
GSM1296033 | D_lesional_day15 | 44.27 | 30 |
GSM1296027 | I_lesional_day15 | 36.81 | 29 |
GSM1296032 | J_lesional_day15 | 128.86 | 45 |
GSM1296024 | K_lesional_day15 | 29.85 | 24 |
GSM1296031 | W_lesional_day15 | 103.98 | 41 |
GSM1296028 | X_lesional_day15 | 59.45 | 34 |
GSM1296029 | Z_lesional_day15 | 53.13 | 32 |
GSM1296026 | F_lesional_day15 | 37.32 | 26 |
GSM1296030 | O_lesional_day15 | 33.26 | 28 |
GSM1296040 | S_lesional_day15 | 59.46 | 33 |
GSM1296036 | T_lesional_day15 | 63.89 | 33 |
GSM1296048 | V_lesional_day15 | 137.02 | 45 |
GSM1296059 | A_lesional_day43 | 123.53 | 45 |
GSM1296066 | G_lesional_day43 | 146.04 | 46 |
GSM1296060 | R_lesional_day43 | 37.14 | 27 |
GSM1296063 | U_lesional_day43 | 75.19 | 36 |
GSM1296064 | E_lesional_day43 | 41.68 | 28 |
GSM1296067 | H_lesional_day43 | 139.32 | 44 |
GSM1296062 | M_lesional_day43 | 58.47 | 33 |
GSM1296068 | Q_lesional_day43 | 185.01 | 49 |
GSM1296050 | C_lesional_day43 | 78.68 | 37 |
GSM1296057 | D_lesional_day43 | 64.72 | 35 |
GSM1296052 | I_lesional_day43 | 52.96 | 34 |
GSM1296054 | J_lesional_day43 | 127.49 | 45 |
GSM1296049 | K_lesional_day43 | 43.61 | 29 |
GSM1296055 | W_lesional_day43 | 110.51 | 42 |
GSM1296053 | X_lesional_day43 | 46.81 | 30 |
GSM1296058 | Z_lesional_day43 | 35.92 | 28 |
GSM1296051 | F_lesional_day43 | 36.77 | 26 |
GSM1296056 | O_lesional_day43 | 65.27 | 36 |
GSM1296065 | S_lesional_day43 | 90.17 | 40 |
GSM1296061 | T_lesional_day43 | 79.45 | 37 |
GSM1296095 | A_non-lesional_pre-dose | 150.62 | 48 |
GSM1296120 | B_non-lesional_pre-dose | 199.47 | 51 |
GSM1296077 | C_non-lesional_pre-dose | 48.29 | 31 |
GSM1296093 | D_non-lesional_pre-dose | 58.69 | 32 |
GSM1296104 | E_non-lesional_pre-dose | 78.26 | 38 |
GSM1296079 | F_non-lesional_pre-dose | 47.93 | 30 |
GSM1296108 | G_non-lesional_pre-dose | 195.47 | 51 |
GSM1296110 | H_non-lesional_pre-dose | 154.11 | 46 |
GSM1296081 | I_non-lesional_pre-dose | 28.76 | 25 |
GSM1296091 | J_non-lesional_pre-dose | 51.26 | 32 |
GSM1296075 | K_non-lesional_pre-dose | 58.34 | 34 |
GSM1296112 | L_non-lesional_pre-dose | 175.37 | 48 |
GSM1296100 | M_non-lesional_pre-dose | 141.27 | 46 |
GSM1296087 | O_non-lesional_pre-dose | 37.77 | 29 |
GSM1296118 | P_non-lesional_pre-dose | 235.56 | 53 |
GSM1296114 | Q_non-lesional_pre-dose | 197.43 | 51 |
GSM1296097 | R_non-lesional_pre-dose | 37.42 | 27 |
GSM1296106 | S_non-lesional_pre-dose | 90.57 | 38 |
GSM1296102 | U_non-lesional_pre-dose | 71.96 | 35 |
GSM1296122 | V_non-lesional_pre-dose | 125.24 | 43 |
GSM1296089 | W_non-lesional_pre-dose | 120.16 | 43 |
GSM1296083 | X_non-lesional_pre-dose | 39.62 | 28 |
GSM1296116 | Y_non-lesional_pre-dose | 148.4 | 45 |
GSM1296085 | Z_non-lesional_pre-dose | 66.8 | 35 |